TTI-0102: cysteamine-pantetheine disulfide

Drug identity checked against registry records

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
A Dose-ranging Study of TTI-0102 in Adults and Children With Leigh Syndrome Spectrum (LSS)NCT06990984Thiogenesis Therapeutics, Inc.Phase 2Not yet recruiting2027-06Estimated

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.